(Q51560189)

7 April 2018

title

Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity. (English)

1 reference

7 April 2018

1 reference

Tsigos C

1

1 reference

7 April 2018

Kyrou I

2

1 reference

7 April 2018

Chala E

3

1 reference

7 April 2018

Tsapogas P

4

1 reference

7 April 2018

Stavridis JC

5

1 reference

7 April 2018

Raptis SA

6

1 reference

7 April 2018

Katsilambros N

7

1 reference

7 April 2018

publication date

1 October 1999

1 reference

7 April 2018

published in

Metabolism

1 reference

7 April 2018

volume

48

1 reference

7 April 2018

issue

10

1 reference

7 April 2018

page(s)

1332-1335

1 reference

7 April 2018

The metabolic effects of tumor necrosis factor and other cytokines

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990277-9

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990277-9

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990277-9

The expression of TNF alpha by human muscle. Relationship to insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990277-9

The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990277-9

Tumor necrosis factor-alpha acutely inhibits insulin signaling in human adipocytes: implication of the p80 tumor necrosis factor receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990277-9

IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990277-9

Dose effects of recombinant human interleukin-6 on pituitary hormone secretion and energy expenditure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990277-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990277-9

Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990277-9

Elevated serum tumour necrosis factor-alpha levels can contribute to the insulin resistance in Type II (non-insulin-dependent) diabetes and in obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990277-9

Cardiovascular risk continuum: implications of insulin resistance and diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990277-9

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990277-9

Tumor necrosis factor-alpha contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990277-9

10.1016/S0026-0495(99)90277-9

7 January 2021

Identifiers

DOI

1 reference

7 April 2018

1 reference

7 April 2018